# Velcade in Myelodysplastic Syndrome - Pilot Study

> **NCT00440076** · PHASE2 · TERMINATED · sponsor: **Gruppo Italiano Malattie EMatologiche dell'Adulto** · enrollment: 28 (actual)

## Conditions studied

- MDS

## Interventions

- **DRUG:** Velcade

## Key facts

- **NCT ID:** NCT00440076
- **Lead sponsor:** Gruppo Italiano Malattie EMatologiche dell'Adulto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-08
- **Primary completion:** —
- **Final completion:** 2008-03
- **Target enrollment:** 28 (ACTUAL)
- **Why stopped:** Low accrual
- **Last updated:** 2015-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00440076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00440076, "Velcade in Myelodysplastic Syndrome - Pilot Study". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00440076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*